Andrea Cesari: Comparing Catheter-Based Reperfusion Strategies for Intermediate-High-Risk PE
Andrea Cesari, Cardiologist at Niguarda Hospital, Milan, shared post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“I am pleased to share our recent multicenter study evaluating catheter-based reperfusion strategies in patients with intermediate-high-risk acute pulmonary embolism (PE).
In the ‘USAT IH-PE‘ registry, we compared ultrasound-assisted catheter-directed thrombolysis (USAT) and mechanical thrombectomy (MT) in a real-world cohort of patients treated during the acute phase of PE.
After propensity-score matching, both approaches were associated with significant improvements in RV function and pulmonary hemodynamics, with comparable 30-day mortality outcomes and low rates of major bleeding.
These findings contribute to the growing body of evidence supporting catheter-based therapies in selected patients with intermediate-high-risk PE, while emphasizing the importance of individualized treatment decisions in contemporary practice.”
Elena Gualini, Cardiologist at Niguarda Hospital, Milan, shared Andrea Cesari‘s post on LinkedIn:
“Happy to share our latest publication, providing real-world evidence on catheter-directed therapies for intermediate-high-risk pulmonary embolism”
Title: Comparative Outcomes of Ultrasound-Assisted Thrombolysis and Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
Authors: Claudia Colombo, Marco Zuin, Filippo Russo, Mario Iannaccone, Marco Solcia, Francesco Musca, Ilaria Emanuela Bossi, Andrea Cesari, Elena Gualini, Federica Fumarola, Alberto Balderi, Francesca Giordana, Andrea Discalzi, Lorenzo Tua, Stefano Buratti, Ruggero Vercelli, Lorenzo Cianfanelli, Marianna Adamo, Alaide Chieffo, Giacomo Bocuzzi, Matteo Montorfano, Fabrizio Oliva, Alice Sacco
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same
-
Jun 28, 2026, 19:02Nassim Emteir: Interpreting TSAT with Ferritin to Guide Iron Deficiency Diagnosis and Treatment
-
Jun 28, 2026, 19:00Andrew Jackson: Predicting PICC-Related Venous Thrombosis in Patients Undergoing Radiotherapy
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients
-
Jun 28, 2026, 09:41Sung-mok Jung: How Environmental Drivers Influence SFTS Occurrence